INTRODUCTION
HIV/AIDS has continued as a leading public health problem globally. Particularly, low income countries such as sub-Saharan African countries are challenged with a widespread of the virus and socio-economic crises due to the disease (1, 2) . Globally, in the previous era, many efforts had been made to fight against the worldwide HIV epidemic (3, 4) . Accessibility of the ART treatment program had scaled-up (3). Hence, almost 10 million people had received the treatment by the end of 2012 (5). Accordingly, the rate of new infections and HIV/AIDS related morbidity and mortality declined significantly (3, 4) . The scaled-up accessibility of ART treatment saved around 2.5 million lives from HIV-related deaths in developing countries, since 1995 (2) .
ART treatment can suppress the viral replication, enhance immunological status, can reduce HIV transmission to uninfected people, and increase patients' life expectancy (6). With the availability of free ART treatment, the cost of ART, and related care is no longer adequate for treatment success and HIV-related mortality reduction (7, 8) . Although efforts such as improving patients' awareness to seek treatment and when to initiate therapy, supporting continuity care, promoting and ensuring high ART adherence rate are vitally important (9).
The level of adherence to ART can vary based on population context, and moreover, it is affected by individual, service, and therapyrelated factors such as substance abuse, psychiatric problems, inability to disclose HIV status, lack of psychosocial support, stigma, drug side effect, pill burden, poor quality service delivery, and unexplained treatment cost (10, 11).
In Ethiopia, HIV epidemic is continuing to be a threat to the lives of many productive age groups (12). In 2007, it was estimated that 977,394 people lived with the virus, and this would result in a total of 71,902 HIV-related deaths. In the same year, the prevalence of HIV in Ethiopia was estimated to be 2.1% (12). However, the national HIV prevalence in 2014 was 1.14% (13). (14) .
The ART adherence is now well understood as the most important determinant (15), and it is the 'Achilles heel' of ART treatment success (16, 17). Poor adherence can lead to preventable HIVrelated deaths. Moreover, it increases the risk of the emerging-drug resistant HIV strains (16, 18). Hence, educating and sustaining ART treatment adherence to the HIV positive individual is the important component which needs public health efforts (19). Due to many factors, a high number of HIV positive individuals are still dropping out from their treatment follow-up (5, 20).
A recent study has shown that the emergence of drug-resistant HIV strains in 'ART-naive people' is increasing (21). According to a World Health Organization (WHO) survey study in 12 developing countries in 2012, the HIV drug resistance rate among people starting ART ranged from 4.8% in 2007 to 6,8% in 2010 (22). Hence, "attention to and strengthening of adherence throughout the entire course of ART comprises an essential part of any successful treatment programme and should be built into the countryspecific program" (20) . Although the magnitude of HIV at the study area was not known, the number of people who were registered to get HIV care and treatment was increasing, and there is limited information about the ART adherence level of people living with HIV/AIDS. Moreover, most peoples living in the study are pastoral and agro-pastorals. Hence, many factors might hinder them to adhere to their ART medications. Currently, the prevalence of HIV is increasing in the rural community. However, regional and the national HIV/AIDS prevention and control programme is unable to reach to investigate the magnitude of the disease, health service quality, individuals' ART adherence level, and their social and behavioural factors that hinder their ART treatment seeking behaviour. Many kinds of research are conducted in well-established towns where most aware individuals about HIV/AIDS live. Therefore, this study was aimed to assess the level of adherence to ART treatment and its associated factors in Hara Town and its surroundings, North-Eastern Ethiopia.
METHODS AND MATERIALS Settings:
The study was done in the ART Unit of Hara Health Center. Hara is in the eastern part of the Amhara Region in North Wollo Zone. It is located at 383km from the regional capital city, Bahir Dar, and 543km from Addis Ababa. The town had a total population of 28,096, (14188 males and 13,908 females). There was one ART clinic, 7 health posts, and 5 private clinics in the town. During this study piloted, there were a total of 454 HIV positive people who were on ART treatment follow-up. Four hundred eighteen patients were enrolled in this study. Study design and period: An institutional facility based cross-sectional study was conducted from April to May 2017 to assess the level of adherence to ART and its associated factors among HIV positive individual in Hara Town and its surroundings, North-Eastern Ethiopia. Study population and eligibility criteria: All HIV positive adults (≥18 years old) who were currently on Highly Active Antiretroviral Therapy (HAART) follow-up at least for 3 months and had no difficulty to communicate were enrolled in this study. However, those patients who were seriously ill during data collection, and those who were under 18 years of age were excluded. Sample size: Single population proportion formula was used to calculate the sample size. We considered the proportion (P) of good adherence from a previous study 85.3% (10), the margin of error 5% at 95% confidence interval. Therefore, the final sample size was 193. However, there were a total of 454 adults who were on ART treatment follow-up in the study setting (ARTclinic); hence, all eligible study subjects were included. Data collection procedures: A structured questionnaire was used as a data collection tool. We adapted the questionnaire partly from the AIDS Clinical Trial Group (ACTG) (23), adherence baseline and follow-up questionnaires. Pilot study was conducted on 5% of the total sample size at Kobo Health Center to check the validity of the questionnaire. The questionnaire includes information on socio-demographics, individual characteristics, and health and economic status of the respondents. The English version of the questionnaire was translated into local language (Amharic) for ease of understansing and it was translated back into the English language to check content validity. Two diploma nurses performed the interview and the data collection using the face-to-face interview method. Training was given to data collectors about the objectives of the study, and how they could approach the patients to obtain their confidentiality. Written and verbal consent was obtained from the study participants after the objectives of the study were explained. Patients' clinical data such as WHO clinical stage and the CD4 counts were retrieved from their medical record registration book at the ART clinic. An antiretroviral therapy adherence level was calculated based on the patients' report of seven days recall of missed doses before the interview date. Data analysis: All the collected data were entered into EPI-Data 3.1 statistical software to code and edit errors, and then transferred into SPSS version 20.0 for analysis. The data were calculated and presented using descriptive statistics. Multivariate logistic regression analysis was performed to identify and check the associated risk factors to adherence. Odds ratio with 95%CI was calculated, and independent variables with p-values of less than 0.05 in multivariate logistic regression analysis were considered significantly associated with adherence. Definition of operational term Adherence: Adherence is defined as good if it is ≥95% (<2 doses of 30 doses or <30 doss of 60 doses is missed) as documented by ART healthcare provider. It is poor if it is between 85-94% (3-5 doses of 30 doses or 3-9 doses of 60 doses is missed) as documented by the ART healthcare provider. Zone Health Department and Hara Health Center. The objective of the study was explained to all study subjects to obtain their verbal or written consent before the interview. Participants were informed that they had the full right to discontinue participating in the study if they felt discomfort. They were also assured that all the data provided by them would be kept confidential. In addition, no personal identifiers were used.
RESULTS

Socio-demographic characteristics:
Out of a total of 454 study participants, 418 people living with HIV and currently on ART follow-up were enrolled in the analysis. The response rate was 92.1%. Thirty-six cases were excluded because they were less than 18 years old. Of the total 418 participants, 246 (58.9%) were females. The mean age of the study participants was 38.17years while 36.6% of them were between the ages of 25-34 years. Of the total, 35.9% were married. The majority, (69.4%) of the study participants were illiterate. Two hundred twenty-seven (54.3%) of them were farmers. The majority, 332 (79.4%) did not get support from their family members to take their medication timely (Table 1) . The adherence measurement was calculated based on the respondents' self-report. In this study, of the total participants, only 71.8% (95% CI: 70.8%-74.4%) reported to have an adherence level of ≥95% in seven days before the interview.
The adherence level of ART in the previous three days prior to the data collection date was 82.5%. The majority of the respondents with poor adherence, 63 (53.4%) had reported that they forget to take their medication timely (Table 3) . (Table 4) .
DISCUSSION
This study assessed patients' ART adherence level and the factors associated with their ART adherence in Hara Town and its surroundings, North-Eastern Ethiopia. The adherence rate was found to be 71.8% in the past seven days of respondents' recall of missed doses. Our result was below the recommended level of good adherence. It must be (≥95%) to suppress the viral load for a long time (8), to bring the patients' clinical improvement and increased pateint's CD4 count (24, 25) This finding revealed a very low adherence level as compared to similar studies in Ethiopia: Gondar (85.3%) (10), Addis Ababa (73.3%) (26), Harar and Dire Dawa (85%) (27), Debre Berhan (95.5%) (28), Gondar (82.7%) (29), Jimma (94.3%) (30), and Jimma (95%) (31). The possible reason for this might be due to the difference in socio-demographic characteristics of participants, and the service quality discrepancy. This result is also lower than other studies conducted in some African countries: Uganda (97%), Namibia (86.1%), and Cameron (76.7% males vs 90.84% females) (24). However, this figure was higher than the study conducted in Ghana, 62.2% (32), rural Zambia (59.9%) (33), Nigeria (70.8%) (17), and Botswana (54%) (34). The low adherence rate In our study, the majority, 63(53.4%) of the respondents reported that forgetfulness was the reason for their nonadherence followed by the transportation problem to the ART-clinic 26 (22%). From predicted associated factors, only respondents who did not disclose their HIV status to their families were 88% less likely to adhere as compared to those who had disclosed their HIV status (AOR: 0.12, 95% CI: 0.05-0.58). A similar findings were reported from Harar and Dire Dawa, Ethiopia, showing that patients who did not disclose their HIV status to their families were 55% less likely to adhere to their medication than those who disclosed their HIV status (AOR: 0.45; 95% CI: 0.21-0.97) (35). This implies that there was still fear of stigma and discrimination to disclose their HIV status to their families. In this finding, drug side effect was another factor which was associated with particpants' adherence to their ART medication. Respondents who had not encountered drug side effect were 2.69 times more likely to adhere to their ART medication than those who had experienced drug side effect (AOR: 2.69, 95%CI: 1.27-5.05). Incomparable to this, another study conducted in Gondar, Ethiopia, reported that respondents with drug side effect were 70% less likely to adhere to ARV therapy than those who did not encounter drug side effect (AOR: 0.3, 95%CI: 0.2-0.5) (10). Another study which was done in the Kathmandu District, Nepal, reported that the odds of adherence among those who did not experience drug side effects were 4.88 times higher than those who reported experiencing drug side effects (36). The severity of drug side effects varies from mild to life threating condition. Therefore, instead of droping out their medication, it is recommended to get a consultation with the 
